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Background: The MS is prevalent in Mexican Americans (MAs) and is projected to increase. It
is important therefore to better understand its genetic and environmental determinants. We
hypothesized that the MS reflects dysfunction in important biological systems. To evaluate this
concept, we analyzed gene expression data for the adaptive-immune, innate-immune, and
hemostasis systems in relation to the MS from a study on MAs of San Antonio and the Rio
Grande Valley.

Methods: We analyzed gene expression data for m=456, 595, and 328 genes found at the
“Reactome” website for the stated systems. SVs are defined as composite variables from
principal component factor analyses (PCFA). PCFA yielded in the order given 118, 109, and 98
SVs explaining at least 80% of the total variance in each system. For a preliminary analysis, we
used a bivariate model for the liability to MS and each SV one at a time, which allows estimation
of genetic and environmental correlations for the trait pair. To control for multiple hypothesis
testing, we controlled the false discovery rate (FDR) to FDR0.1.

Results: The SVs from each system will be referred to by the first 4 letters of the system
followed by its number. There were no significant genetic correlations with MS. However,
significant environmental correlations (where re denotes the environmental correlation
coefficient) with MS were observed for ADAP6 (re=-0.46), ADAP18 (re=0.49), INNA15 (re =0.43), and HEMO11 (re =-0.43).

Conclusions: We found that the MS is environmentally correlated with SVs of the adaptiveimmune, innate-immune, and hemostasis systems.

Introduction/Background:
Metabolic Syndrome (MS) is defined as a condition in which a number of different
disorders are present concurrently in an individual and work to increase the risk of diseases
such as cardiovascular disease, diabetes and cancer. The disorders linked to MS include but
are not limited to, hypertension, dyslipidemia and abdominal obesity. Recent studies show that
individuals affected by MS may have up to a “fivefold increased risk of Type 2 Diabetes and a
twofold increased risk of CVD)” (Lusis et. al, 2008). These findings have opened doors to a
whole new field of research which works to combat the devasting effects that metabolic
diseases have on millions of people worldwide.
For years, researchers used traditional genetics techniques to try and understand the
underlying mechanisms and pathways that are responsible for the progression of MS. These
traditional methods selected clinical traits and then identified single gene variations and
mutations that were responsible for the expression of the selected trait. Unfortunately,
researchers soon realized that this method of research did not take a number of important
interactions into consideration. The genes known to be responsible for the expression of the
disorders present in MS are known to have complex interactions with other genes as well as the
environment. Systems genetics methods are better suited for understanding the interplay of
genes in MS because they “allow for the identification of contributions of small effects from
genetic variations in many genes on traits” (Lusis et. al, 2008). Through these methods, the
interactions between genes are easily seen and understood. For this reason, the introduction of
the systems genetics methods and techniques are promising to bring clarity to the gene
interactions present in MS.
In MS, there is dysfunction in a number of biological systems which causes the adverse
effects seen in the condition. In this study, we work to study the dysfunction in the innate
immune system in individuals with MS. The innate immune system includes cells such as
“macrophages, which are emphasized to play key roles in the pathological process of insulin
resistance” (Zhou et. al, 2018). This is of great importance because we have come to learn that
insulin resistance is a strong player in MS. In order for us to understand the environmental and
genetic correlations between MS and Innate Immunity, we will use a rendition of the systems
biology approach in which we have a combination of a bioinformatics approach and
transcriptomic data for the innate immune system.

Figure 1. Genetic Pathways of the Innate Immune System from Reactome
https://reactome.org/PathwayBrowser/#/R-HSA-168249&SEL=R-HSA-5621481&PATH=R-HSA-168256

Methods:
The San Antonio Family Heart Study (SAFHS) was begun in 1992 as a study on the
genetic epidemiology of cardiovascular disease (CVD) and related metabolic disorders such as
obesity and type 2 diabetes (T2D) (Mitchell et al., 1996). 1236 individuals of Mexican American
descent from 42 extended families residing in San Antonio were recruited for the SAFHS, where
the proband was an individual with at least 6 first-degree relatives willing to participate in the
study. As reported in Mitchell et al. (1996), anthropometric (such as waist circumference (WC))
and systolic and diastolic blood pressure (SBP and DBP) measurements were obtained
following standard protocols at each participant’s clinic visit, and their blood sample drawn, and
appropriately stored. Laboratory work at the Texas Biomedical Research Institute (TBRI; then
called the Southwest Foundation for Biomedical Research) were performed on the blood
samples following standard protocols to obtain fasting glucose (FG), serum triglycerides (TG),
and high density lipoprotein cholesterol (HDLC) (Mitchell et al., 1996).
Using Illumina® technologies—Illumina Sentrix Human Whole Genome (WG-6) Series I
BeadChips, Illumina BeadArray 500GX Reader using Illumina BeadScan image data acquisition
software (version 2.3.0.13), Illumina BeadStudio software (version 1.5.0.34)—in conjunction
with standard protocols for the isolation of total RNA from lymphocytes, gene expression data

were obtained, quality-controlled, and normalized for 20,413 gene transcripts at the appropriate
TBRI laboratories (Göring et al., 2017).
The definition of the metabolic syndrome (MS) developed by the National Cholesterol
Education Program (NCEP) Adult Treatment Panel III (NCEP, 2001) was adopted. As defined
therein, individuals with three or more of the following are considered to have the MS: central
obesity (WC > 102 cm for males or > 88 cm for females), hypertriglyceridemia (TG > 150
mg/dL), low-HDL (HDLC < 40 mg/dL for males and < 50 mg/dL for females), hypertension
(SBP/DBP ≥ 130/85 mmHg or blood pressure medication), and FG ≥ 110 mg/dL.
Using the bioinformatics resources and tools at the public website “Bioreactome”, the set
of genes known to be a part of the adaptive immune, innate immune, and hemostasis systems
were obtained. Respectively in the order just given, 807, 1059, and 660 genes from these
systems were found. For the SAFHS samples, there is adequate gene expression data for the
adaptive immunity, innate immunity, and hemostasis systems for 456, 595, and 328 of the loci
from these three gene sets, respectively. Principal components factor analysis (PCFA)—a
standard tool of systems biology—was used to reduce the dimensionality of these systems. On
applying PCFA, 109, 118, and 98 composite factors respectively for the adaptive immunity,
innate immunity, and hemostasis systems, were found to explain at least 80% of the total
variance in the given system. Denote each composite factor so obtained by SV for “system
variable”. For proof of principle, statistical genetic analysis was performed on the first 20 SVs of
each system.
The bivariate variance components model (Williams et al., 1999) was used to estimate
genetic and environmental correlations between the MS dichotomous trait (defined as 1 for MS,
0 otherwise) and each of the first 20 SVs for each system using the statistical genetics software
SOLAR (Almasy and Blangero, 1998). To control for multiple hypothesis testing, the BenjaminiHochberg false discovery rate was controlled to a significance level of 0.05.

Results and Discussion:
There were no significant genetic correlations with MS. However, significant
environmental correlations (where re denotes the environmental correlation coefficient) with MS
were observed for ADAP6 (re = −0.46), ADAP18 (re = 0.49), INNA15 (re = −0.43), and HEMO11
(re = −0.43).
The observation of no significant genetic correlations between traits representative of
important biological systems with the MS is very unexpected. This does not preclude the
possibility that the naturally occurring genetic variation existing in one or more individual genes

in these systems influences the interindividual variability in risk of MS but rather that, if so, they
are not detectable at the system-wide functional level.
We found that the MS is environmentally correlated with SVs of the adaptive-immune,
innate-immune, and hemostasis systems. This is notable as it indicates that non-permanent
modifiable environmental variables and/or triggers play an important role in the pathogenesis of
MS and that existing behavioral modification paradigms and pharmacological agents may be
able to impact positively on one or more clinical manifestations of this common chronic disorder.
Our findings are consistent with current thinking on the etiology of the MS positing a major role
for the complex interaction between the dietary and gut-microbiome environments (Martinez et
al., 2017; Belizário et al., 2018; Santos-Marcos et al., 2019). In the near future, we hope to
pursue potential links between the SVs reported herein, dietary data from the SAFHS, and
microbiome data for SAFHS that is currently being generated in the laboratory of Professor
Harald Göring.
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